- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips launches high-field MR
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company.
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company. The short-bore Intera Enterprise, announced July 24, also comes in a mobile configuration. Philips executives view the entrepreneurial marketplace as an opportunity for growth. They claim a 30% share in MR sales to this U.S. market segment. The four-channel radio-frequency system supports optimized packages for neuro, orthopedic, body, cardiac, and vascular applications.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
